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The C-type lectin receptors (CLRs) Mincle, Mcl, and Dectin-2 bind mycobacterial and 
fungal cell wall glycolipids and carbohydrates. Recently, we described that expression 
of these CLR is downregulated during differentiation of human monocytes to dendritic 
cells (DC) in the presence of GM-CSF and IL-4. Here, we demonstrate that the Th2 
cytokine IL-4 specifically inhibits expression of Mincle, Mcl, and Dectin-2 in human anti-
gen-presenting cells (APC). This inhibitory effect of IL-4 was observed across species, as 
murine macrophages and DC treated with IL-4 also downregulated these receptors. IL-4 
blocked upregulation of Mincle and Mcl mRNA expression and cell surface protein by 
murine macrophages in response to the Mincle ligand Trehalose-6,6-dibehenate (TDB), 
whereas the TLR4 ligand LPS overcame inhibition by IL-4. Functionally, downregulation 
of Mincle expression by IL-4 was accompanied by reduced cytokine production upon 
stimulation with TDB. These inhibitory effects of IL-4 were dependent on the transcription 
factor Stat6. Together, our results show that the key Th2 cytokine IL-4 exerts a negative 
effect on the expression of Mincle and other Dectin-2 cluster CLR in mouse and human 
macrophages and DC, which may render these sentinel cells less vigilant for sensing 
mycobacterial and fungal ligands.
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inTrODUcTiOn
Following the identification of Dectin-1 as a Syk-coupled activating receptor for bacterial and 
fungal beta-glucans 15 years ago (1), C-type lectin receptors (CLRs) have received increasing atten-
tion as pattern recognition receptors of the innate immune system. The CLR Dectin-2, Mincle, 
and Mcl belong to the so-called Dectin-2 family with their genes adjacent to each other in the 
NK cell receptor gene cluster, localized on human chromosome 12 and mouse chromosome 6 (2). 
Abbreviations: CLR, C-type lectin receptor; FcRγ, Fc receptor gamma chain; IL-4, Interleukin-4; Mincle, macrophage-
inducible-C-type-lectin; Mcl, macrophage C-type lectin; SYK, spleen tyrosine kinase; TDB, trehalose-6,6-dibehenate; TDM, 
trehalose-6,6-dimycolate.
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These  three  receptors  recognize mycobacterial and/or fungal 
ligands, are expressed constitutively or inducibly on innate 
immune cells, and have an emerging role in innate immunity to 
these infections.
Mincle (official gene symbol Clec4e, aka Clecsf9) not only binds 
the mycobacterial cord factor trehalose-6,6-dimycolate (TDM) 
(3, 4), related synthetic glycolipids such as the adjuvant trehalose-
6,6-dibehenate (TDB) (3, 4), but also fungal ligands derived from 
Candida albicans (5–7), Malassezia furfur (8, 9), or Fonsecaea 
spp. (10, 11). More recently, Mcl (official gene symbol Clec4d, 
aka Clecsf8) was identified as a second, low affinity-receptor for 
the mycobacterial cord factor (12), which is required for efficient 
control of experimental mycobacterial infection in mice (13), but 
did not bind to sugar ligands on carbohydrate microarrays (14). 
In contrast, Dectin-2 (gene symbol Clec4n in mice, CLEC6A in 
humans) not only has a classical C-type lectin domain that binds 
structures with high mannose content from numerous pathogens, 
most notably Candida albicans (15, 16), but also mycobacterial 
manLAM (17) and schistosomal egg antigen (18).
Whereas Dectin-1 directly recruits the kinase Syk via a non-
classical ITAM motif in its intracellular domain, Mincle, Mcl, 
and Dectin-2 all associate with the ITAM-containing adapter 
protein Fc receptor gamma chain (FcRγ) to initiate signaling 
through the Card9/Bcl10/Malt1 complex (19). Activation of 
NFκB and MAPK pathways triggers substantial reprograming 
of gene expression in macrophages after activation of Mincle by 
TDB, similar to Curdlan-induced Dectin-1 activation, but only 
partially overlapping with inflammatory gene expression induced 
by TLR ligands (20). Similar to Curdlan, activation of APC by 
TDB or TDM directs a cytokine milieu fostering the development 
of Th17 responses to co-delivered protein antigens via produc-
tion of IL-6, IL-23, and IL-1 (4, 20–24).
Expression of Mincle is strongly inducible in murine mac-
rophages and DC by PAMPs, such as the TLR4 ligand LPS (25) 
or by its ligand TDM itself (4, 12), and depends on the transcrip-
tion factor C/EBPβ (25, 26). Interestingly, Mincle expression 
is constitutively high in murine monocytes and granulocytes 
(21,  27), similar to human monocytes and macrophages (28). 
In  contrast, expression of Mcl is constitutively higher in mouse 
bone marrow-derived macrophages (BMM) and bone marrow-
derived dendritic cells (BMDC), and inducible to a lesser extent 
(12, 26). Dectin-2 expression is predominantly myeloid restricted 
and upregulated by inflammatory stimuli (16). Cytokines involved 
in the upregulation of Dectin-2 include TNF or GM-CSF (29).
IL-4 is the prototypical Th2 cytokine and induces alternative 
macrophage activation through the transcription factor Stat6 
(30). Interestingly, Th2 responses and IL-4 driven alternative 
macrophage activation have been associated with poorer out-
comes in fungal (31) and in mycobacterial infection (32, 33). It is 
well established that IL-4 induces the expression of Dectin-1 (34). 
Its effects on the expression of other CLRs are not well character-
ized, although downregulation of Dectin-2 expression in IL-4 
treated human CD14+ monocytes has been described (29).
We recently observed a strong downregulation of the mRNA 
expression of Mincle, Mcl, and Dectin-2 during differentiation of 
human DC from CD14+ monocytes in the presence of GM-CSF 
and IL-4 in  vitro (28). Here, we investigated the regulation of 
expression of these CLRs by IL-4 in human and mouse APC. 
Our data show that IL-4 specifically downregulates Mincle, Mcl, 
and Dectin-2 expression, but not Dectin-1 expression, in both 
species and impairs Mincle-dependent macrophage activation in 
response to the cord factor analog TDB.
MaTerials anD MeThODs
isolation and culture of human  
antigen-Presenting cells
The use of human leukocytes from healthy donors with written 
informed consent complies with the Declaration of Helsinki 
(Ethical committee Erlangen approval no. 4055 and no. 111_12 B). 
PMBCs were obtained from leukoreduction system chambers by 
density centrifugation (35). Monocytes were positively selected 
from PBMC using α-CD14 microbeads (Miltenyi Biotec), purity 
was ≥90%. For culture, RPMI1640 was supplemented with 10% 
(v/v) fetal calf serum (FCS, Biochrom) and 100 U/ml penicillin 
and 100 μg/ml streptomycin (cRPMI). A total of 50 U/ml GM-CSF 
(Genzyme) or 50 U/ml M-CSF (Peprotech) were added for dif-
ferentiation of macrophages. 50  U/ml GM-CSF and 250  U/ml 
IL-4 (Peprotech) were added for differentiation of DC. Cells were 
cultured at a density of 0.8 × 106 cells/ml (GM-CSF macrophages, 
DC) or 1.6 ×  106 cells/ml (M-CSF macrophages) for 6–7  days 
without change of media at 37°C with 5% CO2 humidified air.
isolation and culture of Mouse 
Macrophages and Dc
C57BL/6, Clec4e−/−, Balb/c, and Stat6−/− mice were bred at the 
Präklinische Experimentelle Tierzentrum of the Medical Faculty 
of the Friedrich-Alexander-University Erlangen-Nürnberg. Mice 
were housed and humanely sacrificed according to regional 
government regulations. Bone marrow cells from femurs and 
tibiae were differentiated to macrophages by culture in complete 
Dulbecco’s Modified Eagle Medium containing 10% FCS, antibi-
otics, and 50 μM β-mercaptoethanol (cDMEM) plus 10% L929-
cell conditioned medium as a source of M-CSF, as previously 
described (36). On day 7, adherent macrophages were harvested 
by Accutase (Sigma) treatment, washed and counted. For gen-
eration of BMDC, bone marrow cells were cultured in cDMEM 
containing 10% conditioned medium of X63 cells producing 
GM-CSF for 7–8 days before harvesting. Peritoneal exudate cells 
(PEC) were obtained on day 4 after injection of mice with 2 ml 
of 4% thioglycollate by flushing the peritoneal cavity with 10 ml 
of ice-cold PBS.
cell stimulation
Human antigen-presenting cells were stimulated by adding 
M-CSF (Peprotech, 50 U/ml), GM-CSF (Genzyme, 50 U/ml), or 
IL-4 (Peprotech, 250  U/ml unless otherwise stated) to the cell 
culture medium before plating of cells into 48 well cell-culture 
plates in a concentration of 0.85  ×  106/ml. Mouse antigen-
presenting cells were stimulated with 10 ng/ml IL-4 (Peprotech), 
10  ng/ml LPS (E. coli serotype O55:B5, Sigma) by adding the 
substance to the cell culture medium before plating of the cells 
into 24 well cell-culture plates in a concentration of 0.5 × 106/ml. 
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TDB (Polar Avanti, 5 μg/ml) was used plate-bound as previously 
described (4, 37), coating with isopropanol only was used as a 
negative control.
mrna expression analysis of clrs
RNA was isolated with Trifast (Peqlab), cDNA was transcribed 
using a cDNA synthesis kit (Applied Biosystems). Expression 
levels of the housekeeping genes hypoxanthine-guanin-
phosphoribosyltransferase (Hprt, mouse) or cyclophilin A 
(PPIA, human), as of the genes of interest, were analyzed using 
primer/probe combinations selected from the Roche Universal 
Probe Library (Roche). For human MINCLE, the primer/probe 
combination was selected using the software PrimerExpress 
(Applied Biosystems). All primers and probes used have been 
described (28) and were purchased from Metabion. ΔCT values 
were calculated as ΔCT = CT(housekeeping gene) − CT(gene of interest) (such 
that higher values indicate higher relative expression), and ΔΔCT 
values referred to the calibrator as indicated.
cytokine elisa
Cytokine concentration of murine G-CSF and TNF-α was ana-
lyzed by sandwich ELISA (DuoSet ELISA, R&D Systems) using 
cell-free cell culture supernatants of cells stimulated as indicated.
Flow cytometry of Mincle and Mcl surface 
receptor levels
The 2 × 105 BMM of C57BL/6 and Mincle−/− mice were stimu-
lated with LPS (10 ng/ml) or TDB (5 μg/ml) in the presence or 
absence of IL-4 (10 ng/ml), as well as with IL-4 alone, for 16 h in 
F-bottom 96 well cell-culture plates. Cell surface expression of 
Mincle and Mcl was analyzed by flow cytometry. Staining was 
performed by using anti-Mincle (clone 4A9, MBL) and anti-Mcl 
(clone 3A4) (38) as primary antibodies, and anti-rat IgG1 con-
jugated to APC as secondary antibody (eBioscience) in a final 
concentration of 1 μg/ml for anti-Mincle and anti-rat IgG-APC 
or 2.27 μg/ml for anti-Mcl. Fc receptors were blocked by adding 
anti-mouse CD16/32 (clone 93, eBioscience) in a final concentra-
tion of 2.5 μg/ml before staining. Cells were stained with primary 
antibodies for 20  min at 4°C, washed, and then stained with 
secondary antibody for 20 min at 4°C. Flow cytometry data were 
acquired on a FACSCanto II instrument (BD); analysis was car-
ried out using FlowJo (version 10).
statistics
Statistical analysis was performed using Prism5 (GraphPad 
Software, v5.01). Student’s t-test was applied as indicated for 
non-paired and paired testing between two groups. *p <  0.05, 
**p < 0.01, ***p < 0.001, ns p > 0.05.
resUlTs
il-4 Downregulates Mincle expression  
in human Monocyte-Derived aPc
In our recent characterization of CLR expression on pri-
mary human antigen-presenting cells, we observed higher 
expression of MINCLE mRNA in macrophages generated 
with M-CSF or GM-CSF compared to DC differentiated in 
the presence of GM-CSF plus IL-4 (28). This effect was con-
firmed in independent experiments using cells from unrelated 
healthy donors, showing a strong reduction in the ΔCT values 
from around −4.05 (M-CSF) and −5.0 (GM-CSF) to −10.4 
(GM-CSF + IL-4) (Figure 1A). Quantitative RT-PCR analysis 
of mRNA expression for a range of CLR showed that the reduced 
expression in DC compared to GM-CSF-derived macrophages 
was selectively observed for MINCLE, MCL, DECTIN2, and 
CLEC12A whereas expression levels of the other tested CLR 
were not significantly different (Figure 1B). Since the presence 
of IL-4 in the cell culture media was the main difference in the 
differentiation protocols for GM-CSF macrophages and DC, 
we tested whether IL-4 alone would be sufficient to downregu-
late MINCLE expression in monocyte cultures (Figure  1C). 
MINCLE expression was highest in freshly isolated CD14+ 
monocytes and declined over time during culture in media 
alone. However, addition of IL-4 caused a stronger reduction, 
and this effect was detectable at all time points tested (6–144 h). 
The presence of GM-CSF kept MINCLE expression at a high 
level, but additional IL-4 induced strong downregulation, which 
was again detectable already after 6h, but increased over time 
(Figure 1C). The inhibitory effect of IL-4 on MINCLE expres-
sion by monocytes was dose dependent and already detected 
with 0.25 U/ml IL-4 but more pronounced at concentrations 
above 2.5 U/ml (Figure 1D). Having shown that IL-4 inhibits 
MINCLE expression in monocytes early during differentia-
tion cultures, we next asked whether the same effect was seen 
when adding IL-4 to macrophages or DC after differentiation. 
While the expression of MINCLE in monocyte-derived DC 
cultured in media only was relatively variable and the reduc-
tion observed for the average values in DC treated with IL-4 
was not significant, both types of macrophages responded with 
significant downregulation of MINCLE when treated with IL-4 
for 48 h (Figure 1E).
il-4 also Downregulates Mincle 
expression in Murine antigen-Presenting 
cells
We next asked whether the regulatory action of IL-4 is conserved 
between species and tested the expression of mouse macrophages 
and DC treated for 48 h with IL-4 (Figure 2). IL-4 was used at 
the saturating concentration of 10  ng/ml (39). Mincle mRNA 
levels in M-CSF-driven BMM under basal conditions were lower 
than those in d4 thioglycollate-elicited peritoneal exsudate cells 
(PEC) or GM-CSF-driven BMDC, but IL-4 decreased Mincle 
expression in all three cell types significantly (Figure 2A). Mcl 
expression was comparably high in untreated BMM, PEC, and 
BMDC and strongly inhibited by IL-4 (Figure  2B). Dectin-2 
mRNA was highest in BMDC and significantly downregulated by 
IL-4 in BMM and BMDC (Figure 2C). In contrast, IL-4 did not 
inhibit Dectin-1 expression in mouse APC, but in fact increased 
Dectin-1 mRNA in BMM, confirming a previous report (34) 
(Figure 2D). Together, the pattern of IL-4 effects on expression 
of the CLR family members examined was very similar between 
FigUre 1 | il-4 downregulates Mincle mrna expression in human antigen-presenting cells. (a) Monocyte-derived DC express less MINCLE than 
monocyte-derived macrophages. Human CD14+ cells were differentiated for 6 days in the presence of M-CSF or GM-CSF (to obtain macrophages) or GM-
CSF + IL-4 (to obtain dendritic cells). After that, MINCLE mRNA levels were measured using qPCR. The data are depicted as mean ± SD of ΔCT values 
(Ct[PPIA] − Ct[MINCLE]) of cells from eight independent blood donors. (B) Reduced expression in DC is restricted to MINCLE, MCL, DECTIN2, and CLEC12A. Gene 
expression of human GM-CSF-elicited macrophages was compared to dendritic cells (induced via GM-CSF + IL-4) after 6 days of differentiation using qPCR. The 
data are depicted as mean ± SD of ΔΔCT values (using GM-CSF Mϕ as calibrators) from 6 independent blood donors. (c) IL-4 is sufficient to reduce MINCLE 
expression in human CD14+ cells. CD14+ peripheral blood mononuclear cells were stimulated as indicated. MINCLE expression was determined using qPCR. The 
data are depicted as mean ± SD (n = 2 for d0, n = 4 for d0.25, and n = 6 for all other time points). Asterisks indicate significant p-values for the comparison “IL-4 
vs. untreated”, crosses for the comparison “GM-CSF + IL-4 vs. GM-CSF”. (D) Dose-dependence of IL-4 effect. CD14+ peripheral blood mononuclear cells were 
stimulated with increasing concentrations of IL-4 for 24 h. Mean ± SD of ΔCT values for MINCLE expression of cells from four independent donors. (e) Human 
CD14+ monocyte-derived M-CSF or GM-CSF elicited macrophages and dendritic cells were stimulated with IL-4 or left untreated for 48 h. Subsequently, MINCLE 
expression was determined using qPCR. The data are depicted as mean ± SD of cells from four independent blood donors. Statistical significance was tested using 
a paired t-test. *p < 0.05, **p < 0.01, ***p < 0.001, †††p < 0.001.
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FigUre 2 | mrna expression of Mincle, Mcl, and Dectin-2 is downregulated by il-4 on murine antigen-presenting cells. Murine bone marrow-derived 
macrophages (BMM, black bars), thioglycolate-elicited peritoneal macrophages (PEC, gray bars), or bone marrow-derived dendritic cells (BMDC, white bars) treated 
or not with IL-4 for 48 h were analyzed by qRT-PCR for expression of mRNA encoding Mincle (a), Mcl (B), Dectin-2 (c), or Dectin-1 (D). Mean ± SD of ΔCT values 
from eight (BMM) or three (PEC and BMDC) independent experiments. Statistical significance was tested using a paired t-test. *p < 0.05, **p < 0.01, ***p < 0.001.
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mouse and human, with significant downregulation of Mincle, 
Mcl, and Dectin-2, whereas Dectin-1 was not affected or even 
upregulated by IL-4.
Differential regulation of TDB- or  
lPs-inducible Mincle expression by il-4
Expression of Mincle is strongly inducible by pattern recognition 
receptor signaling, such as TLR or CLR (4, 25, 40). Therefore, 
we examined the effect of IL-4 on Mincle mRNA expression in 
BMM treated with the TLR4 ligand LPS or the Mincle ligand TDB 
(Figure 3). Stimulation with LPS or TDB for 48 h significantly 
induced Mincle expression, as expected; the concomitant expo-
sure to IL-4 inhibited Mincle upregulation by TDB, but not by LPS 
(Figure 3A). Priming of BMM with LPS or LPS + IL-4 overnight, 
followed by removal of LPS and washing before addition of IL-4, 
also abrogated the inhibitory effect of IL-4 on Mincle expression 
(Figure 3B). Thus, the inhibitory effect of IL-4 on Mincle expres-
sion could be overcome by stimulation of macrophages with the 
TLR4 ligand LPS.
il-4 abrogates cell surface expression of 
Mincle and Mcl Protein in response to 
TDB but not lPs
We next employed flow cytometry to determine the cell surface 
levels of Mincle and Mcl in resting and stimulated macrophages 
(Figures 4A,B). Confirming previous reports (40, 41), only weak 
staining with the Mincle- and Mcl-specific monoclonal antibod-
ies (4A9 and 3A4) was detected in resting macrophages. In fact, 
using Mincle-deficient macrophages as staining controls, only 
a minimal increase in the fluorescence signal for Mincle was 
observed. Overnight stimulation with TDB caused upregulation 
of Mincle and Mcl on a significant fraction of the macrophage 
population. However, this increase was almost completely pre-
vented by co-treatment with IL-4. In contrast, the LPS-induced 
surface staining for Mincle and Mcl was found on the entire 
macrophage population and was only weakly reduced in the 
presence of IL-4. Together, the changes in cell surface protein 
levels and mRNA expression of Mincle and Mcl showed a close 
correlation.
FigUre 4 | regulation of cell surface levels of Mincle and Mcl in 
murine macrophages by il-4. Bone marrow-derived macrophages were 
analyzed for Mincle (a) and Mcl (B) surface expression 16 h after 
stimulation as indicated by using anti-Mincle (4A9) or anti-Mcl (3A4) 
primary antibodies followed by staining with APC-conjugated secondary 
antibody. (a) Histograms show Mincle surface expression in C57BL/6 
BMMs (wt) stimulated with TDB or LPS or left untreated (Mock) in 
presence (gray filled) or absence (red filled) of IL-4 as indicated. Mincle−/− 
BMMs (blue dotted) were stimulated with TDB or LPS or left untreated and 
used as negative control. Histograms are from one representative 
experiment. Scatter plot shows Mincle expression depicted as percentage 
of APC-positive cells from C57BL/6 BMMs after stimulation with TDB or 
LPS in presence or absence of IL-4 or left untreated (Mock). Data are 
depicted from two independent experiments performed in duplicates (filled 
symbols: exp. 1, open symbols: exp. 2). (B) Histograms and scatter plot 
show Mcl surface expression, respectively. Cells were treated as described 
in (a). Statistical significance was tested using an unpaired t-test. 
**p < 0.01, ***p < 0.001.
FigUre 3 | lPs overcomes il-4-induced downregulation of Mincle 
mrna expression. (a) Murine bone marrow-derived macrophages were 
treated with TDB or LPS, with or without IL-4, or were left untreated for 48 h. 
(B) LPS-priming abrogates the effect of IL-4 on Mincle expression. Bone 
marrow-derived murine macrophages were primed overnight with LPS 
(P: LPS) or left untreated (P: -). The next day, LPS was washed off, the cells 
were re-plated and cultivated for 48 h with or without IL-4. Mincle expression 
was determined with qPCR. The data are depicted as mean ± SD of ΔCT 
values from five independent experiments. Statistical significance was tested 
using a paired t-test. **p < 0.01.
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il-4 inhibits g-csF and TnF expression 
and secretion by Macrophages in 
response to TDB
We reasoned that inhibition of Mincle expression in mac-
rophages treated with IL-4 may functionally impair the response 
to the Mincle ligand TDB. To test this hypothesis, we determined 
the levels of the cytokines G-CSF and TNF, which are robustly 
secreted by macrophages stimulated with TDB or with LPS 
although the levels varied considerably between independent 
experiments (Figures  5A,B). Macrophages treated with IL-4 
or media alone did not produce significant amounts of G-CSF 
or TNF (data not shown). Concomitant treatment with IL-4 
strongly and consistently inhibited the production of both 
cytokines in response to TDB (Figures 5A,B). In contrast, LPS-
induced G-CSF was inhibited less strongly by IL-4 (Figure 5A), 
and the LPS-induced release of TNF was not affected by IL-4 
(Figure 5B).
FigUre 5 | il-4 inhibits TDB-induced cytokine production in murine macrophages. Bone marrow-derived macrophages were stimulated for 24 h with TDB 
or LPS in the presence or absence of IL-4. Cytokine levels in cell culture supernatant were quantified using ELISA [(a), G-CSF, and (B), TNF]. (a,B) Depicted are 
mean ELISA values of replicates from six independent experiments. Supernatants of BMM treated with media or IL-4 alone did not contain significant amounts of 
G-CSF or TNF (data not shown). Statistical significance of the effect of IL-4 on stimulation with TDB and LPS, respectively, was tested using a two-sided paired 
t-test. *p < 0.05, ***p < 0.001.
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negative regulation of Mincle expression 
and Target gene expression by il-4 
requires stat6
IL-4 triggers Jak-Stat signaling, with Stat6 being the pivotal tran-
scription factor for IL-4-induced gene expression (42). We inves-
tigated whether the inhibitory effect of IL-4 was also dependent 
on this transcription factor by using Stat6−/− BMM in comparison 
to the respective Balb/c wild type control BMM (Figure 6). The 
Stat6 genotype had no effect on the basal (data not shown) or 
TDB-induced Mincle expression (Figure  6A). However, IL-4 
inhibited the basal (data not shown) and TDB-induced Mincle 
expression in Balb/c BMM, but not in Stat6−/− BMM (Figure 6A). 
Similarly, the TDB-inducible expression of G-CSF at the mRNA 
and protein level was strongly inhibited in Balb/c BMM, but not 
in Stat6−/− BMM, where in fact a moderate increase in G-CSF 
protein secretion production was evident (Figures 6B,C).
DiscUssiOn
Expression of pattern recognition receptors is a prerequisite for 
sensitive detection of microbial pathogens and is often restricted 
to specialized cell types of the innate immune system. While the 
CLR Mincle, Dectin-2, and Mcl are all expressed in myeloid cells, 
their expression levels are differentially affected by microbial 
and inflammatory stimuli. In this manuscript, we show that 
the prototypical Th2 cytokine IL-4 downregulates expression 
of these members of the Dectin-2 family, but not of other CLR, 
e.g., Dectin-1. Importantly, this inhibitory effect of IL-4 was 
conserved across species, as it was detected in human as well as 
murine APC. Reduced receptor expression may be functionally 
relevant, because production of cytokines in response to the 
Mincle ligand TDB was reduced in IL-4-treated macrophages. 
Our findings raise several questions concerning the mechanism 
and potential consequences of Dectin-2 family regulation by IL-4 
during immune responses.
Signaling by the IL-4 receptor activates the transcrip-
tion factor Stat6, which is required for most transcriptional 
responses (42). Therefore, the dependence of negative regula-
tion of Mincle expression on Stat6 was not surprising. Further 
investigation will be required to determine in detail how Stat6 
mediates directly or indirectly the decrease in Mincle mRNA 
expression. One possibility is that Stat6 interferes with the 
recruitment of activating transcription factors to the promoter/
enhancer regions of Mincle, Mcl, and Dectin-2. The transcrip-
tion factor C/EBPβ is essential for the inducible expression of 
Mincle, as shown already by Matsumoto et al. in 1999 (25), but 
also for upregulation of Dectin-2 and Mcl in response to TDB, 
whereas it is not required for Dectin-1 expression (26). Thus, 
the inhibitory effect of IL-4 and the requirement for C/EBPβ 
in inducible receptor expression correlate. It is conceivable 
that IL-4 may downregulate C/EBPβ at the transcriptional or 
post-transcriptional level in macrophages. Stat6 and C/EBPβ 
cooperate in the induction of several genes associated with Th2 
responses (43) and alternative macrophage activation, such as 
Arginase-1 (44, 45). However, to our knowledge, no inhibition 
of C/EBPβ-dependent transcriptional responses by Stat6 has 
been described to date. To answer these questions, chromatin 
immunoprecipitation assays for direct binding of C/EBPβ and 
Stat6 to the promoter regions of Mincle, Mcl, and Dectin-2 will 
be required in future experiments.
Although IL-4 potently inhibited Mincle expression dur-
ing differentiation of DC from human monocytes or in mouse 
macrophages, strikingly, the concurrent stimulation or priming 
of macrophages with the TLR4 ligand LPS overcame the IL-4 
effect and prevented Mincle downregulation (Figure 3). It is pos-
sible that LPS interferes with IL-4 signaling through induction of 
negative regulators, such as Socs1 (46, 47). However, LPS did not 
8Hupfer et al. IL-4 Downregulates Mincle
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 423
FigUre 6 | il-4-mediated inhibition of TDB-induced Mincle expression and g-csF production is sTaT6-dependent. Bone marrow-derived macrophages 
from STAT6-deficient mice and Balb/c wild-type controls were stimulated for 48 h with TDB in the presence or absence of IL-4. Mincle and G-CSF expression was 
determined by qPCR (a,c), and G-CSF concentration in the cell supernatant was obtained using ELISA (B). ELISA values were normalized to TDB-induced G-CSF 
production. Mean ± SD of four independent experiments. Statistical significance was tested using a paired t-test. *p < 0.05, **p < 0.01.
block the induction of IL-4 induced Arginase-1 expression but 
rather synergistically induced it (data not shown), suggesting that 
the abrogation of the inhibitory IL-4 effect on Mincle expression 
likely involves other mechanisms. Regardless of the mechanism, 
it appears that TLR ligands make macrophages unresponsive to 
IL-4-triggered downregulation of Mincle expression. This effect 
would be consistent with the notion that the presence of TLR 
ligands signals the requirement for continued high level expres-
sion of CLR, regardless of other signals which otherwise would 
reduce their expression.
We have also shown here that macrophages treated with IL-4 
not only express less Mincle but also fail to respond to TDB 
stimulation with upregulation of Mincle and Mcl (Figures 3 and 
4), and of the cytokines G-CSF and TNF (Figure 5), indicating 
that reduced receptor expression may lead to weaker mac-
rophage activation in response to mycobacterial cord  factor. 
It  remains  to be tested in the future whether IL-4-induced 
downregulation of Mincle, Mcl, and Dectin-2 functionally 
impairs innate recognition of and the response to mycobacteria 
and fungi. From a technical point of view, our results also 
 suggest that the use of growth factors and cytokines in protocols 
for generation of DC and macrophages, i.e. inclusion of IL-4 or 
not, may have strong effects on the response to CLR ligands. In 
the case of mycobacteria, the combined recognition of TDM 
by Mincle and Mcl, and of manLAM by Dectin-2, would be 
affected by IL-4, which may lead to compromised macrophage 
responsiveness to mycobacteria. It is interesting to speculate 
that in Th2-primed individuals reduced expression of Mincle, 
Mcl, and Dectin-2 on myeloid cells may occur, which could 
impair the detection of mycobacteria, and thereby could con-
tribute to increased susceptibility to mycobacterial infection. 
Coinfection with helminths and M. tuberculosis is prevalent 
in many parts of the world. Epidemiological data show that 
exposure of household contacts to patients with active pulmo-
nary TB resulted in higher risk to develop latent tuberculosis 
in the case of concurrent helminth infection, consistent with 
an impaired capacity of the innate immune cells, in this case 
alveolar macrophages, to kill mycobacteria upon inhalation (48). 
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